Study: Avapritinib Shows No Adverse Effects in Phase II Trial for Systematic Mastocytosis
A PIONEER trial has been conducted in order to evaluate the effects of avapritinib, a drug meant to treat systematic mastocytosis. Researchers want to find a better treatment for…